Evidence map›Paper›PMID 35664725›Full record

ArticleIranian journal of microbiology2022

High frequency of SCC

Toktam Sadeghi Moghaddam, Mohammad Hasan Namaei, Davoud Afshar, Masoud Yousefi

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Iranian journal of microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The First Report of t8463 and t605Archives of Razi Institute · 2024
    Article
  5. Molecular and Clinical Features of Heterogeneous Vancomycin-IntermediateSultan Qaboos University medical journal · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Toktam Sadeghi MoghaddamStudent Research Committee, Birjand University of Medical Sciences, Birjand, Iran.
Mohammad Hasan NamaeiInfectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.
Davoud AfsharDepartment of Microbiology and Virology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
Masoud YousefiInfectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.
Birjand University of Medical Sciences · IRZanjan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objectives: The ever-increasing of antibiotic resistance in methicillin-resistant Materials and Methods: In this cross-sectional study, the antibiotic susceptibility patterns of 109 clinical Results: The prevalence of MRSA isolates was 39.4%. Linezolid, vancomycin, and ceftaroline were the most effective agents against MRSA isolates. The incidence of multidrug-resistant (MDR) and resistance to most antibiotics were significantly higher in MRSA than methicillin-susceptible Conclusion: Our findings demonstrated a high rate of MDR among MRSA isolates. The high existence of SCC

Indexed as

Drug resistancemecA geneMethicillin-resistant Staphylococcus aureusMolecular typingMultidrug-resistantPolymerase chain reaction

Identifiers

PMID35664725
PMCPMC9085546
OpenAlexW4213040653

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.